Name: ABSA’s 1st Biosecurity Symposium
Start: 2021-04-20T00:00:00-05:00
End: 2021-04-23T23:59:59-05:00
Location: Renaissance Depot Hotel

Rapid Identification of Ricin in Serum Samples Using LC–MS/MS

Validated Methods for Removing Select Agent Samples from BSL-3 Labs

by Global Biodefense Staff October 19, 2020, 3:36 pm
Q Fever Endocarditis and C. burnetii Infections in Greece

by Global Biodefense Staff September 7, 2020, 10:03 am
Funding for Preclinical Development of Countermeasures Against Select Pathogens

by Global Biodefense Staff June 8, 2020, 6:01 pm
Promising Results from Phase 1 Trial of Equine Encephalitis Virus Vaccine

by Global Biodefense Staff June 8, 2020, 7:47 am
NIAID to Hold Closed Meeting on Biodefense Medical Countermeasure Funding

by Global Biodefense Staff May 7, 2020, 7:12 am
Marburg Infection Protective Antibody Response Mechanism Uncovered

by Global Biodefense Staff April 21, 2020, 2:00 pm
New Universal Ebola Vaccine May Fight All Four Virus Species that Infect Humans

by Global Biodefense Staff April 16, 2020, 11:15 am
USAMRIID Resumes Full Operations Following Federal Select Agent Program Reinstatement

by Global Biodefense Staff April 1, 2020, 2:12 pm
Critical Bioeconomy Asset in Need of Attention: BSL-3 and BSL-4 Laboratories in the U.S.

by Global Biodefense Staff March 6, 2020, 3:02 pm
CCD Detector System for Abrin Toxin Activity

by Global Biodefense Staff March 6, 2020, 2:05 pm
Tandem Mass Spec for Select Agent Detection

by Global Biodefense Staff March 6, 2020, 2:03 pm
Passive Immunization with mAbs Against Aerosolized Ricin Toxin

by Global Biodefense Staff March 6, 2020, 2:03 pm
A Call to Action on Plague Research

by Global Biodefense Staff February 28, 2020, 8:02 pm
Belarus Man Indicted for Mailing Ricin and Threats to Pelican Bay State Prison

by Global Biodefense Staff February 27, 2020, 6:34 pm

Congratulations. You've reached the end of the internet.

Select Agents

Rapid Identification of Ricin in Serum Samples Using LC–MS/MS

Targeting the Shell of the Ebola Virus for a Knock-Out with Antivirals

BARDA Awards Medical Countermeasures Clinical Studies Network Contracts

Draft Policy Issued for Large Animal Outdoor Containment Select Agent Studies

Validated Methods for Removing Select Agent Samples from BSL-3 Labs

Q Fever Endocarditis and C. burnetii Infections in Greece

Funding for Preclinical Development of Countermeasures Against Select Pathogens

Promising Results from Phase 1 Trial of Equine Encephalitis Virus Vaccine

NIAID to Hold Closed Meeting on Biodefense Medical Countermeasure Funding

Marburg Infection Protective Antibody Response Mechanism Uncovered

New Universal Ebola Vaccine May Fight All Four Virus Species that Infect Humans

USAMRIID Resumes Full Operations Following Federal Select Agent Program Reinstatement

Critical Bioeconomy Asset in Need of Attention: BSL-3 and BSL-4 Laboratories in the U.S.

CCD Detector System for Abrin Toxin Activity

Tandem Mass Spec for Select Agent Detection

Passive Immunization with mAbs Against Aerosolized Ricin Toxin

A Call to Action on Plague Research

Belarus Man Indicted for Mailing Ricin and Threats to Pelican Bay State Prison

Biodefense Headlines – 21 January 2021

First Cases of B.1.1.7 Variant COVID-19 Detected in Washington State

The Response Measures Database: Central Archive of COVID-19 Interventions

EU Initiative on Health Security Work Programme 2021

Rapid Identification of Ricin in Serum Samples Using LC–MS/MS

Dr. Fauci Makes First Appearance at Biden White House Press Briefing – Transcript

ASM Expresses Support for the Global Health Security Act of 2021

How and When Will Lower-Income Countries Gain Access to COVID-19 Vaccines?

OHDSI Awarded $10M FDA Contract to Monitor Safety and Effectiveness of Vaccines, Biologics

Neutralizing Norovirus: NIAID Monoclonal Antibodies Licensing Opportunity

NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats

Emerging Infections Network – Managing Travelers Who Acquire Disease Abroad

Upcoming Events

Application Deadline: Expanding Existing Research Grants, CRADAs for Novel Coronavirus Response

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 2

Systematizing the One Health Approach in Preparedness and Response Efforts for Infectious Disease Outbreaks

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 3

ABSA’s 1st Biosecurity Symposium

Latest stories

Latest Articles